Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
62M
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
51.8M
-
Shares change
-
+2.26M
-
Total reported value, excl. options
-
$1.31B
-
Value change
-
+$54.4M
-
Put/Call ratio
-
0.86
-
Number of buys
-
68
-
Number of sells
-
-60
-
Price
-
$25.19
Significant Holders of MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) as of Q3 2020
157 filings reported holding MGNX - MACROGENICS INC - Common Stock, par value $0.01 per share as of Q3 2020.
MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.8M shares
of 62M outstanding shares and own 83.62% of the company stock.
Largest 10 shareholders include Bellevue Group AG (5.28M shares), BlackRock Inc. (4.78M shares), Invesco Ltd. (4.48M shares), RA CAPITAL MANAGEMENT, L.P. (4.38M shares), Consonance Capital Management LP (3.75M shares), Point72 Asset Management, L.P. (3.6M shares), VANGUARD GROUP INC (3.3M shares), WASATCH ADVISORS INC (2.43M shares), STATE STREET CORP (2.31M shares), and GREAT POINT PARTNERS LLC (1.51M shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.